Form 4: UnitedHealth Group Director Acquires Additional Shares Through Dividend Equivalents
SEC Form 4 Filing
John H. Noseworthy, a director at UnitedHealth Group, acquired 24 shares of common stock through dividend equivalents paid on vested deferred stock units.
Summary
- On March 18, 2025, John H. Noseworthy, a director of UnitedHealth Group, acquired 24 shares of common stock.
- The acquisition was a result of dividend equivalents paid on vested deferred stock units.
- Following the transaction, Noseworthy directly owns 5,583 shares of UnitedHealth Group common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive as it reflects a routine transaction related to executive compensation and dividend payouts, indicating a healthy return on existing investments.
Positives
- The acquisition of shares through dividend equivalents reflects a positive return on existing vested deferred stock units.
Future Outlook
This Form 4 filing does not contain any forward-looking statements regarding UnitedHealth Group's future performance or outlook.
Industry Context
This filing reflects routine transactions related to executive compensation and ownership in a large, publicly traded healthcare company. It is typical for directors to receive stock-based compensation and dividend equivalents.
Comparison to Industry Standards
- Director compensation packages often include stock options, restricted stock units (RSUs), and dividend equivalents to align their interests with shareholders, similar to practices at companies like Cigna, Anthem (now Elevance Health), and Humana.
- The number of shares acquired through dividend equivalents is relatively small compared to the overall holdings of the director, which is consistent with standard executive compensation practices.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders as it involves a small number of shares acquired by a director.
Key Dates
| Date | Description |
|---|---|
| 03/18/2025 | Date of transaction: Acquisition of 24 shares of common stock through dividend equivalents. |
| 03/20/2025 | Date of signature for the Form 4 filing. |
Keywords
UnitedHealth Group, Director, Share Acquisition, Dividend Equivalents, Form 4, Noseworthy, UNH, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.